ACTRN12609000319279CompletedNot Applicable
The effect of lapband surgery on weight loss in diabetic Indigenous Australians.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Monash University
- Enrollment
- 210
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 20 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •Patients must:
- •-1. Be Indigenous people who suffer obesity and type 2 diabetes
- •-1. Agree to comply with the procedures of the study including questionnaire assessment
- •2.Have no history of previous abdominal surgery which would potentially preclude laparoscopic placement of the band.
- •3.Be free of medical issues which contra-indicated the proposed treatments. These may include acute myocardial infarction within the past 6 months, dementia, active psychosis, concurrent experimental drug use, pregnancy or intending to conceive in the next two years, lactation, severe alcohol or drug abuse, use of drugs known to affect body composition, cytotoxic drugs, internal malignancy, or major organ failure.
- •4.Be able to understand the Lapband (LAGB) procedure and its potential for benefit and risk.
Exclusion Criteria
- •Patients would be excluded from entry -:
- •1.If there was lack of acceptance of the procedures of the study including questionnaire assessment
- •2.If there was a history of previous abdominal surgery which would potentially preclude laparoscopic placement of the band.
- •3.If there were medical issues which contra-indicated the proposed treatments. These may include acute myocardial infarction within the past 6 months, dementia, active psychosis, concurrent experimental drug use, pregnancy or intending to conceive in the next two years, lactation, severe alcohol or drug abuse, use of drugs known to affect body composition, cytotoxic drugs, internal malignancy, or major organ failure.
- •4.If there was an inability to understand the LapBand (LAGB) procedure and its potential for benefit and risk or were unable to understand or agree to the aftercare process.
Investigators
Similar Trials
Completed
Not Applicable
Weight loss to prevent diabetes in obese people with impaired fasting glucosediabetes mellitusMetabolic and Endocrine - DiabetesMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityObesityACTRN12613000548730Prof Paul O'Brien300
Completed
Not Applicable
Effect of bariatric surgery dependent weight loss on gut barrier function and the inflammatory statusE66ObesityDRKS00009008Else Kröner-Fresenius Zentrum für Ernährungsmedizn, Lehrstuhl für Ernährungsmedizin, Technische Universität München48
Completed
Not Applicable
Effects of weight loss on adipose tissue β2-adrenoceptor-stimulated lipolysis: role of adipose tissue oxidative stress and hypoxiavetweefseldisfunctie bij obesitasobesityNL-OMON36127niversiteit Maastricht37
Completed
Phase 4
Study for the effect of visceral fat reduction by SGLT2 inhibitor Ipragliglozinin patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000014058Hokkaido University Hospital26
Completed
Not Applicable
A prospective study of the effects of weight loss on knee pain, function and appearance on x-ray in severely obese women.Knee painDiet and Nutrition - ObesityMusculoskeletal - OsteoarthritisACTRN12605000171617Centre for Obesity Research and Education (CORE) Monash University100